Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Colgate-Palmolive Company (CL - Free Report) is a leading global consumer products company. The Zacks Consensus Estimate for its current year earnings has been revised 0.3% downward over the last 30 days.
Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States. The Zacks Consensus Estimate for its current year earnings has been revised 2.4% downward over the last 30 days.
TPG RE Finance Trust, Inc. (TRTX - Free Report) is a commercial real estate finance company. The Zacks Consensus Estimate for its current year earnings has been revised 1.7% downward over the last 30 days.
Libbey, Inc. is the leading producer of glass tableware in the U.S. and Canada. The Zacks Consensus Estimate for its current year earnings has been revised 61.4% downward over the last 30 days.
ThyssenKrupp AG Sponsored ADR (TKAMY - Free Report) engages in the production of steel. The Zacks Consensus Estimate for its current year earnings has been revised 57.1% downward over the last 30 days.
View the entire Zacks Rank #5 List.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Colgate-Palmolive Company (CL - Free Report) is a leading global consumer products company. The Zacks Consensus Estimate for its current year earnings has been revised 0.3% downward over the last 30 days.
Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States. The Zacks Consensus Estimate for its current year earnings has been revised 2.4% downward over the last 30 days.
TPG RE Finance Trust, Inc. (TRTX - Free Report) is a commercial real estate finance company. The Zacks Consensus Estimate for its current year earnings has been revised 1.7% downward over the last 30 days.
Libbey, Inc. is the leading producer of glass tableware in the U.S. and Canada. The Zacks Consensus Estimate for its current year earnings has been revised 61.4% downward over the last 30 days.
ThyssenKrupp AG Sponsored ADR (TKAMY - Free Report) engages in the production of steel. The Zacks Consensus Estimate for its current year earnings has been revised 57.1% downward over the last 30 days.
View the entire Zacks Rank #5 List.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on CL - FREE
Get the latest research report on TKAMY - FREE
Get the latest research report on TRTX - FREE